Lastest Insider Transactions Of Intellia Therapeutics, Inc. ( NTLA )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
NTLAIntellia Therapeutics, Inc.Sepp-Lorenzino LauraEVP, Chief Scientific Officer2024-01-08Sell2,27528.8765,6822024-01-10 16:15:19
NTLAIntellia Therapeutics, Inc.LEONARD JOHN MPresident and CEO2024-01-03Sell19,22329.46566,3102024-01-05 16:51:05
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical Officer2024-01-03Sell5,84329.46172,1352024-01-05 16:50:36
NTLAIntellia Therapeutics, Inc.Sepp-Lorenzino LauraEVP, Chief Scientific Officer2024-01-03Sell5,53229.46162,9732024-01-05 16:50:26
NTLAIntellia Therapeutics, Inc.Goddard GlennEVP, Chief Financial Officer2024-01-03Sell5,36529.46158,0532024-01-05 16:49:15
NTLAIntellia Therapeutics, Inc.Hicks DerekEVP, Chief Business Officer2024-01-03Sell3,87729.46114,2162024-01-05 16:46:39
NTLAIntellia Therapeutics, Inc.BASTA JAMESEVP, General Counsel2024-01-03Sell3,80529.46112,0952024-01-05 16:45:39
NTLAIntellia Therapeutics, Inc.Clark ElianaEVP, Chief Technical Officer2024-01-03Sell4,60829.50135,9542024-01-05 16:44:43
NTLAIntellia Therapeutics, Inc.Sepp-Lorenzino LauraEVP, Chief Scientific Officer2024-01-01Option Exercise3,5000.0002024-01-03 17:35:50
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical Officer2024-01-01Option Exercise3,1870.0002024-01-03 17:34:10
NTLAIntellia Therapeutics, Inc.LEONARD JOHN MPresident and CEO2024-01-01Option Exercise7,8480.0002024-01-03 17:30:40
NTLAIntellia Therapeutics, Inc.Goddard GlennEVP, Chief Financial Officer2024-01-01Option Exercise3,0620.0002024-01-03 17:28:42
NTLAIntellia Therapeutics, Inc.Bhanji MunaDirectior2023-10-31Sell26523.906,3342023-11-02 16:42:59
NTLAIntellia Therapeutics, Inc.Bhanji MunaDirectior2023-07-31Sell26542.3311,2172023-08-02 17:19:39
NTLAIntellia Therapeutics, Inc.Bhanji MunaDirectior2023-07-06Sell1,86739.3073,3732023-07-10 17:21:43
NTLAIntellia Therapeutics, Inc.Clark ElianaEVP, Chief Technical Officer2023-07-03Sell36040.5114,5842023-07-06 15:34:22
NTLAIntellia Therapeutics, Inc.Clark ElianaEVP, Chief Technical Officer2023-06-20Sell5,00045.00225,0002023-06-22 17:52:19
NTLAIntellia Therapeutics, Inc.Clark ElianaEVP, Chief Technical Officer2023-06-20Option Exercise5,00012.2761,3502023-06-22 17:52:19
NTLAIntellia Therapeutics, Inc.BASTA JAMESEVP, General Counsel2023-03-01Sell1,08843.8847,7412023-03-03 17:10:35
NTLAIntellia Therapeutics, Inc.Sepp-Lorenzino LauraEVP, Chief Scientific Officer2023-01-04Sell4,83837.82182,9822023-01-06 17:39:56
NTLAIntellia Therapeutics, Inc.LEONARD JOHN MPresident and CEO2023-01-04Sell6,67337.21248,3022023-01-06 17:32:49
NTLAIntellia Therapeutics, Inc.Hicks DerekEVP, Chief Business Officer2023-01-04Sell1,81237.2167,4252023-01-06 17:29:43
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical Officer2023-01-04Sell2,57437.2195,7792023-01-06 17:26:38
NTLAIntellia Therapeutics, Inc.Goddard GlennEVP, Chief Financial Officer2023-01-04Sell2,42737.2190,3092023-01-06 17:23:40
NTLAIntellia Therapeutics, Inc.Clark ElianaEVP, Chief Technical Officer2022-07-01Sell2,02837.6576,3572023-01-06 17:21:01
NTLAIntellia Therapeutics, Inc.BASTA JAMESEVP, General Counsel2023-01-04Sell1,13837.2142,3452023-01-06 17:19:11
NTLAIntellia Therapeutics, Inc.Sepp-Lorenzino LauraEVP, Chief Scientific Officer2023-01-01Option Exercise3,5000.0002023-01-04 20:38:29
NTLAIntellia Therapeutics, Inc.LEONARD JOHN MPresident and CEO2023-01-01Option Exercise7,8480.0002023-01-04 20:36:01
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical Officer2023-01-01Option Exercise3,1870.0002023-01-04 20:33:03
NTLAIntellia Therapeutics, Inc.Goddard GlennEVP, Chief Financial Officer2023-01-01Option Exercise3,0620.0002023-01-04 20:29:37